Sivik Global Healthcare LLC Biogen Inc. Transaction History

Sivik Global Healthcare LLC

$236 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$190.52 - $236.72 $3.8 Million - $4.73 Million	19,966 Added 198.98%	30,000 $6.96 Million
Q1 2024 Apr 30, 2024	SELL	$212.02 - $267.71 $3.17 Million - $4.01 Million	-14,966 Reduced 59.86%	10,034 $2.16 Million
Q4 2023 Feb 05, 2024	BUY	$222.59 - $267.94 $5.56 Million - $6.7 Million	25,000 New	25,000 $6.47 Million
Q3 2022 Nov 04, 2022	BUY	$194.69 - $268.46 $1.95 Million - $2.68 Million	10,000 New	10,000 $2.67 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $5.66 Million - $7.38 Million	-20,000 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$259.0 - $414.71 $1.94 Million - $3.11 Million	7,500 Added 60.0%	20,000 $6.93 Million
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $3.04 Million - $3.56 Million	12,500 New	12,500 $3.5 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $2.84 Million - $4.27 Million	-12,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $794,310 - $917,129	-3,000 Reduced 20.0%	12,000 $3.4 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $1.29 Million - $1.71 Million	-5,000 Reduced 25.0%	15,000 $4.01 Million
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $4.4 Million - $6.08 Million	20,000 New	20,000 $5.94 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $3.29 Million - $3.63 Million	-15,000 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $1.08 Million - $1.69 Million	-5,000 Reduced 25.0%	15,000 $3.55 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $696,250 - $881,875	2,500 Added 14.29%	20,000 $6.02 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $1.47 Million - $1.92 Million	-5,000 Reduced 22.22%	17,500 $6.18 Million
Q2 2018 Aug 06, 2018	BUY	$257.52 - $306.91 $1.93 Million - $2.3 Million	7,500 Added 50.0%	22,500 $6.53 Million
Q1 2018 May 08, 2018	SELL	$260.13 - $367.91 $1.3 Million - $1.84 Million	-5,000 Reduced 25.0%	15,000 $4.11 Million
Q4 2017 Feb 08, 2018	SELL	$307.64 - $344.58 $769,100 - $861,450	-2,500 Reduced 11.11%	20,000 $6.37 Million
Q3 2017 Nov 08, 2017	BUY	$281.15 - $329.69 $6.33 Million - $7.42 Million	22,500	22,500 $7.05 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.49 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.43 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.17 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.09 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$765 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.

Account